N@N

Sunesis to Present at Upcoming Investor Conferences

^{Published on 2010-06-03 04:40:42 - Market Wire}
 

SOUTH SAN FRANCISCO, CA--(Marketwire - June 3, 2010) - Sunesis Pharmaceuticals, Inc. (NASDAQ: [ SNSS ]), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at three upcoming conferences:

• 9th Annual Needham Healthcare Conference
  Wednesday, June 9 at 10:40 a.m. EDT
  New York Palace Hotel, New York City

• Jefferies 2010 Global Life Sciences Conference
  Thursday, June 10 at 8:00 a.m. EDT
  Grand Hyatt, New York City

• ThinkEquity Mid Year Check-Up on Healthcare
  Wednesday, June 16 at 11:30 a.m. EDT
  The Princeton Club, New York City

A live webcast of the Jefferies presentation on June 10^th will be available on the Sunesis website at [ http://ir.sunesis.com ]. A replay of that webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks following the presentation.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis, please visit [ http://www.sunesis.com ].

SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.